El-Hussuna Alaa, Hauer Almuthe Christina, Karakan Tarkan, Pittet Valerie, Yanai Henit, Devi Jalpa, Yamamoto-Furusho Jesus K, Sima Ali Reza, Desalegn Hailemichael, Sultan Mutaz Idrees, Sharma Vishal, Shehab Hany, Mrabti Lamya, Queiroz Natalia, Jena Anuraag, Darma Andy, Davidson Karin, Avellaneda Nicolas, Elhadi Muhammed, Roslani April, Wickramasinghe Dakshitha, Cajucom Carlo Angelo, Sebastian Shaji
Department of Surgery, Odda-Helse Fonna, Haugesund, Norway; OpenSourceResearch Collaboration (OSRC.network), Aalborg, Denmark.
Department of Paediatrics and Adolescent Medicine, Medical University of Graz, Graz-Austria.
J Crohns Colitis. 2025 Jul 12. doi: 10.1093/ecco-jcc/jjaf125.
The incidence and prevalence of inflammatory bowel disease [IBD] have increased significantly in low- and middle-income countries [LMICs] in recent decades. Managing IBD in these settings presents substantial challenges. This consensus aims to describe the epidemiology of IBD in LMICs and to highlight the key challenges in its diagnosis and treatment.
The consensus-defining strategy followed the previous European Crohn's and Colitis Organisation [ECCO] consensus guidelines [available at www.ecco-ibd.eu]. The authors reviewed the available evidence and formulated statements accordingly. Provisional ECCO statements and supporting text were drafted based on a comprehensive literature review and further refined through two voting rounds, which included external reviewers and national representatives from ECCO's 36 member countries. The final ECCO statements, representing a consensus of at least 80% agreement among participants, were approved during an online meeting. Consensus statements should be interpreted in context with their accompanying commentary rather than in isolation and should not be used solely to guide patient management. The supporting text was finalized under the guidance of each working group leader [VP, HY, TK, AH] and subsequently integrated by the consensus leader [AE].
Data on IBD epidemiology in LMICs remain limited. Public and healthcare professional awareness and timely access to early diagnostic modalities, advanced medical and surgical therapies, and specialist multidisciplinary care are key gaps in IBD care in LMICs. The complexity and chronic nature of IBD, along with the necessity for a multidisciplinary approach, pose significant challenges to adopting a holistic management strategy in LMICs.
There is a critical need for further studies to assess the specific needs of LMICs. Such research will help guide resource allocation and improve IBD management in these settings.
近几十年来,炎症性肠病(IBD)在低收入和中等收入国家(LMICs)的发病率和患病率显著上升。在这些地区管理IBD面临重大挑战。本共识旨在描述LMICs中IBD的流行病学情况,并强调其诊断和治疗中的关键挑战。
共识定义策略遵循先前的欧洲克罗恩病和结肠炎组织(ECCO)共识指南(可在www.ecco - ibd.eu获取)。作者回顾了现有证据并据此制定声明。基于全面的文献综述起草了ECCO临时声明及支持文本,并通过两轮投票进一步完善,两轮投票的参与者包括外部评审员以及来自ECCO 36个成员国的国家代表。在一次在线会议期间批准了最终的ECCO声明,该声明代表参与者中至少80%的一致意见。共识声明应结合其附带的评论进行解读,而非孤立看待,并且不应仅用于指导患者管理。支持文本在每个工作组组长(VP、HY、TK、AH)的指导下最终确定,随后由共识负责人(AE)整合。
LMICs中IBD流行病学的数据仍然有限。公众和医疗保健专业人员的认知以及及时获得早期诊断方法、先进的药物和手术治疗以及专科多学科护理是LMICs中IBD护理的关键差距。IBD的复杂性和慢性本质,以及多学科方法的必要性,给在LMICs中采用整体管理策略带来了重大挑战。
迫切需要进一步研究以评估LMICs的具体需求。此类研究将有助于指导资源分配并改善这些地区的IBD管理。